1. Home
  2. SLGL vs GNS Comparison

SLGL vs GNS Comparison

Compare SLGL & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • GNS
  • Stock Information
  • Founded
  • SLGL 1997
  • GNS 2002
  • Country
  • SLGL Israel
  • GNS Singapore
  • Employees
  • SLGL N/A
  • GNS N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • GNS Other Consumer Services
  • Sector
  • SLGL Health Care
  • GNS Real Estate
  • Exchange
  • SLGL Nasdaq
  • GNS Nasdaq
  • Market Cap
  • SLGL 21.1M
  • GNS 17.8M
  • IPO Year
  • SLGL 2018
  • GNS 2022
  • Fundamental
  • Price
  • SLGL $7.24
  • GNS $0.42
  • Analyst Decision
  • SLGL Buy
  • GNS
  • Analyst Count
  • SLGL 1
  • GNS 0
  • Target Price
  • SLGL $40.00
  • GNS N/A
  • AVG Volume (30 Days)
  • SLGL 13.2K
  • GNS 4.1M
  • Earning Date
  • SLGL 05-23-2025
  • GNS 04-30-2025
  • Dividend Yield
  • SLGL N/A
  • GNS N/A
  • EPS Growth
  • SLGL N/A
  • GNS N/A
  • EPS
  • SLGL N/A
  • GNS N/A
  • Revenue
  • SLGL $12,103,000.00
  • GNS $7,912,718.00
  • Revenue This Year
  • SLGL N/A
  • GNS $233.65
  • Revenue Next Year
  • SLGL $31.17
  • GNS $570.20
  • P/E Ratio
  • SLGL N/A
  • GNS N/A
  • Revenue Growth
  • SLGL 603.66
  • GNS N/A
  • 52 Week Low
  • SLGL $3.34
  • GNS $0.21
  • 52 Week High
  • SLGL $16.50
  • GNS $3.37
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 50.26
  • GNS 62.23
  • Support Level
  • SLGL $7.15
  • GNS $0.31
  • Resistance Level
  • SLGL $7.45
  • GNS $0.33
  • Average True Range (ATR)
  • SLGL 0.32
  • GNS 0.05
  • MACD
  • SLGL -0.10
  • GNS 0.00
  • Stochastic Oscillator
  • SLGL 31.36
  • GNS 92.31

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.

Share on Social Networks: